# Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma

> **NCT00292955** · PHASE2 · UNKNOWN · sponsor: **University of Virginia** · enrollment: 30 (estimated)

## Conditions studied

- Cancer of the Cervix

## Interventions

- **DRUG:** Cetuximab

## Key facts

- **NCT ID:** NCT00292955
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-02
- **Primary completion:** 2012-02
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-05-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00292955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00292955, "Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00292955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*